Featured Interview: CEO Phillipe Deschamps of Helius Medical Technologies, Inc. (NASDAQ: HSDT)

Phillipe Deschamps of Helius Medical Technologies, Inc. (NASDAQ: HSDT), returns to Stock Day to discuss their PoNS technology and therapy platform, working with Health Canada, and possible timeline for receiving FDA results.

The CEOs interviewed on the Stock Day Podcast did not incur any charges for their time with Uptick Newswire CEO Everett Jolly. Contact us at (602) 441-3474 if you would like further information.